Peptides for neurodegenerative conditions Neurodegenerative diseases, Alzheimer, Parkinson, multiple sclerosis, ALS, share a common thread despite their different presentations
Whether BPC-157s neurological effects are mediated partly through gut-brain axis signaling or are primarily the result of direct central nervous system activity remains an open question in the literature
The peptide appears to modulate NMDA receptor activity, potentially reducing excessive neural stimulation[1]
Most human research was conducted during the 1980s or early 1990s
In particular, respondents working with female child victims of domestic sex trafficking reported that these girls often viewed the pimp or trafficker as their boyfriend and everyone else as the enemy, part of the tactic used by the trafficker to isolate and control the girls
Since gut motility decreases when someone is hypothyroid, constipation is common